Atlas Trials

A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT Imaging

Clinical trial NCT06769893 · RECRUITING

Trial details

NCT number
NCT06769893
Sponsor
Xijing Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
RCC, Renal Cell Cancer
Start date
2024-06-12
Primary completion
2025-04-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.